Astellas Pharma Inc. at its board meeting held on April 27, 2021 approves the resignation of Keiko Yamagami as Director. This change is subject to approval at the 16th Term Annual Shareholders Meeting and a decision at the Board of Directors meeting, both scheduled on June 18, 2021.